Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes

DOI10.1111/J.1541-0420.2011.01679.XzbMATH Open1274.62795OpenAlexW2115067514WikidataQ41867314 ScholiaQ41867314MaRDI QIDQ2912356FDOQ2912356

Authors: Joseph G. Ibrahim, Ming-Hui Chen, H. Amy Xia, Thomas Liu 

Publication date: 14 September 2012

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3571108

Recommendations

• A Bayesian Approach to the Design of Phase II Clinical Trials
• Is the FDA too conservative or too aggressive?: a Bayesian decision analysis of clinical trial design
• Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials
• Bayesian design of noninferiority trials for medical devices using historical data
• An empirical Bayes method for multivariate meta-analysis with an application in clinical trials

zbMATH Keywords

simulationfitting priorsampling priorsurvival datapartial borrowing power prior

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Bayesian sample size determination for binomial proportions
• Sampling and Bayes' Inference in Scientific Modelling and Robustness
• Bayesianly justifiable and relevant frequency calculations for the applied statistician
• A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models
• Bayesian survival analysis
• Bayesian design of noninferiority trials for medical devices using historical data

Cited In (6)

• On efficient posterior inference in normalized power prior Bayesian analysis
• Discussion of ``Optimal test procedures for multiple hypotheses controlling the familywise expected loss by Willi Maurer, Frank Bretz, and Xiaolei Xun
• The scale transformed power prior for use with historical data from a different outcome model
• Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
• Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials
• Normalized power prior Bayesian analysis

This page was built for publication: Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2912356)